What Brand Intimacy Means for Consumers

What immediately pops up in your head when you hear the word intimacy?

Definitely, not food, said Barbara Castiglia of the podcast “Modern Restaurant Management.” But that may change thanks to a dedicated study by MBLN that tracks trends and researches the relationship everyday people have with food brands.

“The MBLN for 12 years has been focused on what they refer to as brand intimacy studies. What they do is they rank brands … based on emotion,” said Castiglia.

The agency looked closely at over 600 brands for their analysis and examined over a billion words to determine the companies or intimate brands that elicited more positive feelings from consumers. They released the Brand Intimacy Study 2022 earlier this year and Castiglia noted their category for fast food chains. She cited companies like Krispy Kreme, which currently ranks number one in regard to brand intimacy, per Yahoo News, along with Costa Coffee, Starbucks, Cinnabon, Outback Steakhouse, and McDonald’s. Those brands were among the top ten, according to the study.

Additionally, she highlighted another aspect of the study, which looked at several words consumers used to showcase their relationship to said brands and their products. And not to much surprise, given modern phone technology, consumers aren’t always using words to indicate such.

“Interesting, the top keywords for the top three [brands] were emojis … so not even really words but this is how people were expressing their connection to a brand,” said Castiglia.

But evidently, fast food didn’t even rank that high when it came to the overall categories that MBLN studied. Castiglia said fast food fell in the “bottom 40 percent of all industries.”

The MBLN surveyed 19 different industries and fast food ranked 12th. The top sector was media and entertainment. Within that industry, Disney clinched the No. 1 spot, per The Walt Disney Company.

MBLN cited that nostalgia was a driving force behind consumer appeal to Disney and that over 55 percent of consumer commentary about the company fell within intimacy.

Castiglia said an eye-opener in the study was how many of the top-performing companies and brands were in the “indulgence” category. She also mentioned that there was a shift toward comfort food during the peak of the pandemic, and follow-up studies in the coming year or two can likely reveal another shift.

Conclusively, the study revealed that certain brands have different stakes when it comes to performing well amongst their consumers, said Castiglia. So much so that many of these brands even outperform the Fortune 500 companies when it comes to profit, via MBLM.

This fact means that it’s vital for brands to learn a lot more about their consumers and the types of connections they have with them. Castiglia added that this connection is so strong that it shows consumer loyalty that will benefit these brands in the long run.

“Interesting to note that what these really kind of teach people is how people engage with a brand, and one great phrase that came out of this little survey is: ‘Consumers are willing to pay more for intimate brands and less willing to live without them.’ So that just shows you the deep connection people have for certain brands,” said Castiglia.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More